協和キリンの株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2020/04/01 | 2,421 | 2,444 | 2,267 | 2,295 | -127 | -5.2% | 1,171,000 |
2020/03/31 | 2,471 | 2,497 | 2,407 | 2,422 | -70 | -2.8% | 1,501,400 |
2020/03/30 | 2,415 | 2,498 | 2,389 | 2,492 | -8 | -0.3% | 2,182,600 |
2020/03/27 | 2,400 | 2,500 | 2,400 | 2,500 | +197 | +8.6% | 2,364,300 |
2020/03/26 | 2,318 | 2,376 | 2,269 | 2,303 | -37 | -1.6% | 1,430,400 |
2020/03/25 | 2,386 | 2,399 | 2,226 | 2,340 | +104 | +4.7% | 1,979,900 |
2020/03/24 | 2,139 | 2,239 | 2,113 | 2,236 | +147 | +7% | 2,775,700 |
2020/03/23 | 1,902 | 2,149 | 1,875 | 2,089 | +207 | +11% | 3,837,500 |
2020/03/19 | 2,035 | 2,047 | 1,849 | 1,882 | -110 | -5.5% | 3,817,900 |
2020/03/18 | 2,034 | 2,078 | 1,988 | 1,992 | -9 | -0.4% | 2,596,200 |
2020/03/17 | 2,019 | 2,091 | 1,964 | 2,001 | -64 | -3.1% | 3,182,500 |
2020/03/16 | 2,151 | 2,188 | 2,044 | 2,065 | -67 | -3.1% | 1,787,200 |
2020/03/13 | 2,094 | 2,208 | 2,023 | 2,132 | -138 | -6.1% | 2,687,200 |
2020/03/12 | 2,354 | 2,362 | 2,263 | 2,270 | -120 | -5% | 2,163,800 |
2020/03/11 | 2,393 | 2,409 | 2,362 | 2,390 | -28 | -1.2% | 1,604,400 |
2020/03/10 | 2,412 | 2,427 | 2,339 | 2,418 | -20 | -0.8% | 1,982,300 |
2020/03/09 | 2,514 | 2,514 | 2,410 | 2,438 | -126 | -4.9% | 1,609,500 |
2020/03/06 | 2,574 | 2,585 | 2,538 | 2,564 | -30 | -1.2% | 1,453,700 |
2020/03/05 | 2,536 | 2,597 | 2,510 | 2,594 | +112 | +4.5% | 2,100,400 |
2020/03/04 | 2,556 | 2,565 | 2,473 | 2,482 | -81 | -3.2% | 1,548,300 |
2020/03/03 | 2,672 | 2,672 | 2,563 | 2,563 | -43 | -1.7% | 1,921,000 |
2020/03/02 | 2,520 | 2,637 | 2,515 | 2,606 | +36 | +1.4% | 2,114,700 |
2020/02/28 | 2,589 | 2,661 | 2,549 | 2,570 | -35 | -1.3% | 2,725,800 |
2020/02/27 | 2,619 | 2,635 | 2,589 | 2,605 | -17 | -0.6% | 1,531,700 |
2020/02/26 | 2,632 | 2,648 | 2,588 | 2,622 | -32 | -1.2% | 1,584,000 |
2020/02/25 | 2,602 | 2,668 | 2,592 | 2,654 | -48 | -1.8% | 1,476,400 |
2020/02/21 | 2,731 | 2,757 | 2,696 | 2,702 | -8 | -0.3% | 1,331,200 |
2020/02/20 | 2,766 | 2,781 | 2,703 | 2,710 | -46 | -1.7% | 1,041,900 |
2020/02/19 | 2,755 | 2,779 | 2,735 | 2,756 | -3 | -0.1% | 1,166,500 |
2020/02/18 | 2,802 | 2,811 | 2,716 | 2,759 | -56 | -2% | 927,600 |
2020/02/17 | 2,829 | 2,843 | 2,790 | 2,815 | -15 | -0.5% | 1,298,000 |
2020/02/14 | 2,796 | 2,858 | 2,770 | 2,830 | +28 | +1% | 1,282,700 |
2020/02/13 | 2,768 | 2,828 | 2,755 | 2,802 | +34 | +1.2% | 1,859,700 |
2020/02/12 | 2,785 | 2,804 | 2,753 | 2,768 | +6 | +0.2% | 1,232,000 |
2020/02/10 | 2,812 | 2,814 | 2,756 | 2,762 | -69 | -2.4% | 952,800 |
2020/02/07 | 2,745 | 2,836 | 2,741 | 2,831 | +75 | +2.7% | 1,518,400 |
2020/02/06 | 2,757 | 2,789 | 2,722 | 2,756 | +118 | +4.5% | 2,520,600 |
2020/02/05 | 2,653 | 2,660 | 2,628 | 2,638 | -11 | -0.4% | 1,246,100 |
2020/02/04 | 2,606 | 2,652 | 2,605 | 2,649 | +28 | +1.1% | 1,162,100 |
2020/02/03 | 2,575 | 2,650 | 2,555 | 2,621 | +35 | +1.4% | 1,409,700 |
2020/01/31 | 2,575 | 2,630 | 2,574 | 2,586 | +3 | +0.1% | 1,477,000 |
2020/01/30 | 2,599 | 2,624 | 2,567 | 2,583 | -40 | -1.5% | 1,256,100 |
2020/01/29 | 2,601 | 2,635 | 2,572 | 2,623 | -12 | -0.5% | 1,028,600 |
2020/01/28 | 2,627 | 2,644 | 2,619 | 2,635 | -18 | -0.7% | 932,200 |
2020/01/27 | 2,570 | 2,658 | 2,568 | 2,653 | -17 | -0.6% | 984,500 |
2020/01/24 | 2,645 | 2,695 | 2,642 | 2,670 | +40 | +1.5% | 1,636,300 |
2020/01/23 | 2,614 | 2,645 | 2,592 | 2,630 | -22 | -0.8% | 1,395,000 |
2020/01/22 | 2,644 | 2,654 | 2,623 | 2,652 | +4 | +0.2% | 737,200 |
2020/01/21 | 2,631 | 2,658 | 2,631 | 2,648 | +1 | ±0% | 1,005,300 |
2020/01/20 | 2,608 | 2,655 | 2,600 | 2,647 | +36 | +1.4% | 1,021,200 |
1251~
1300
件表示中 / 3698件
類似銘柄と比較する
現在ご覧いただいている「協和キリン」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
協和キリン | 216,100円 | -3.5% | -11.3% | 2.78% | 19.85倍 | 1.33倍 |
|
キリン傘下。医薬品、バイオが主力。独自の抗体高活性化技術に強み。富士フイルムと提携 |
アステラス薬 | 133,500円 | +0.9% | +380.2% | 5.84% | 18.39倍 | 1.58倍 |
|
医薬品国内2位。開発技術起点の研究開発体制。前立腺がん薬が柱。遺伝子・細胞治療技術育成 |
塩野義 | 219,000円 | +20.9% | +10.6% | 3.01% | 10.35倍 | 1.37倍 |
|
抗HIV薬が大型製品に。感染症、疼痛・中枢神経領域に強み。米国に積極展開。欧州、アジア開拓 |
エーザイ | 381,500円 | +1.7% | -2.9% | 4.19% | 25.03倍 | 1.32倍 |
|
神経系、がん領域に強み。認知症薬は米バイオジェンと、抗がん薬では米メルクと国際協業推進 |
小野薬 | 149,200円 | +0.6% | +43.3% | 5.36% | 10.46倍 | 0.89倍 |
|
医療用医薬品専業の中堅。自社開発品多い。先駆的がん免疫阻害剤「オプジーボ」が成長牽引 |
市場注目の銘柄
チャート関連のコラム